Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Литература.

  1. Барях Е.А., Кравченко С.К., Обухова Т.Н., и соавт. Лимфома Беркитта: клиника, диагностика, лечение. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2009;2(2):137- 146
  2. Soussain C, Patte C, Ostronoff M, et al. Small non-cleaved cell lymphoma and leukemia in adult. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood. 1995;85:664-674
  3. Magrath I, Adde M, Shad A, et al. Adult and children with small noncleaved- cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925-934
  4. Hoelther D, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 1996;87:495-508
  5. Thomas D, Cortes J, O’Brien S, et al. Hyper-CVAD program in Burkitt’s type adult acute lymphoblastic leukemia. J Clin Oncol. 1999;17:2461-2470
  6. Lopez JM, Hagemeister FB, MgLaughlin P, et al. Small noncleaved cell lymphoma in adult: superior results for stage I-III disease. J Clin Oncol, 1990;8:615-622
  7. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol. 1991;9:123-132
  8. Patte C, Philip T, Rodary C, et al. Improved survival rate in children with stage III-IV B-cell non-Hodgkin lymphoma and leukemia using multiagent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol. 1986;8:1219-1226
  9. Patte C, Bernard A, Hartmann O, et al. High-dose metotrexate and continuous infusion Ara-C in childhood NHL. Pediatr Hematol Oncol. 1986;3:11-18
  10. Schwenn M, Blattner S, Lynch E, Weinstein H. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt’s lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol. 1991;9:133-138
  11. Bowman W, Shuster J, Cook B, et al. Improved survival for children with B- cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a Pediatric Oncology group study. J Clin Oncol, 1996;14:1252- 1261
  12. Reiter A, Schrappe M, Ludwig WD, et al. Favorable outcome of B- cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood. 1992; 90: 2471-2478.
  13. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM-90. Blood. 1999;94(10):3294-3306
  14. Cамочатова Е. В., Островская А. В., Карачунский А.И. и др. Значение верификации варианта неходжкинских лимфом у детей для эффективности лечения по современным протоколам Гематол. и трасфузиол. 2000;6:9-14
  15. Самочатова Е.В., Алейникова О.В., Беликова Л.Ю. и др. Неходжкинские лимфомы у детей: клиническая характеристика, возможности диагностики и терапии; по данным клиник России и Беларуссии. Гематол. Трансфузиол. 2001; 46(1): 3-10
  16. Тюкалова Н. P., Федоpова А. С., Шумилова И. В., Pумянцев А. Г. Неходжкинские лимфомы у детей: клиническая хаpактеpистика, возможности диагностики и теpапии; по данным клиник Pоссии и Белаpуси . Гематология и трансфузиология. 2002;3:58
  17. Murphy S., Bowman W., Abromovitch M. et al. Results of treatment of advanced-stage Burkitt’s lymphoma and B-cell (S Ig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986;4:1732-1739
  18. Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin lymphoma. N Engl J Med. 1997;337:1259
  19. Soussain C, Patte C, Ostronoff M, et al. Small noncleaved cell lymphoma and leukemia in adult. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood. 1995;85:664-674
  20. Spreafico F, Massimino M, Luksch R, et al. Intensive, very short-term chemotherapy for advanced Burkitt’s lymphoma in children. J Clin Oncol. 2002;20(12):2783-2788
  21. Bernstein JI, Coleman CN, Strickler JG, et al. Combineted modality therapy for adult with small noncleaved cell lymphoma (Burkitt’s and Burkitt-like type). J Clin Oncol. 1986;4:847-858
  22. Coiffier B, Bryon PA, French M, et al. Intensive chemotherapy in agressive lymphomas: Updated results of LNH-80 protocol and prognostic factors affecting response and survival. Blood.1987;70:1394
  23. Finlay J, Trigg M, Link M, et al. Poor-risk non-lymphoblastic lymphoma of childhood: result of an intensive pilot study. Med Pediatr Oncol. 1989;17:29
  24. Fenaux P, Lai JL, Miaux O, et al. Burkitt acute leukemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol. 1989;71:371-376
  25. Mead GM, Barrans SL, Qian W, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood. 2008;12:2248-2260
  26. Patte C, Auperin A, Michon J, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370-3379.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

Литература.
На предыдущую главу Предыдущая глава
оглавление
Следующая глава